Gastric biopsy specimens were obtained from 83 patients without peptic ulcer disease and analysed histologically. Culture and serological studies were done on the last 64 patients. The patients were divided into two age groups (young and old groups.) In 34 patients with chronic superficial gastritis, gastric campylobacter-like organisms (GCLO) were identified histologically in 91% and grown on culture in 88%: antibody to GCLO was detected in 81%. No age-related difference in the prevalence of the organism was demonstrated. In the 23 patients with atrophic gastritis (all elderly), presence of the organisms appeared to be related to the presence ofan inflammatory cell infiltrate into the gastric mucosa.
Introduction
Warren & Marshall in 1983' reported the presence of gastric campylobacter-like organism (GCLO) on the gastric mucosa and showed that the organism is associated with histological gastritis. Subsequently, their findings have been confirmed in various studies, both prospective2'3 and retrospective.' It has been suggested that the organism may have a causative role in the pathogenesis of peptic ulcer5 but this has not been confirmed by Koch's criteria.
GCLO is a spiral Gram-negative organism with up to five unipolar flagellae living in the mucous layer of the gastric surface ( Figure 1 ). It is morphologically distinct from Campylobacter jejuni and is as yet bacteriologically unclassified.
Most of the previous studies have included patients with and without peptic ulcer. This study was designed to investigate the presence of the organism in patients without peptic ulcer or reflux oesophagitis and to compare the prevalence in young and elderly patients.
Patients and methods

Patients
Gastric biopsy specimens were obtained from the antrum and mid-greater curve of 83 patients without endoscopic evidence of peptic ulcer disease or reflux oesophagitis. Two age groups were studied, 20 to 50 years (young group, mean age 37 years, 16 females, 23 
Methods
Histology Samples were orientated on filter paper, fixed in buffered formaldehyde and embedded in JB4 resin (Polysciences Inc). Sections were stained with haematoxylin and eosin. Histological classification of cases into groups consisting of normals, chronic superficial gastritics and atrophic gastritics was accomplished according to the criteria of Whitehead.6 Sections were scanned for the presence ofGCLO in the mucous layer adjacent to the gastric epithelium using a x 40 objective lens.
Culture and serology Culture and serological studies were carried out in the last 64 consecutive patients enrolled in the study, according to the methods described previously,2 Antibody to GCLO was measured by complement fixation test (using a sonicate of the organism as antigen), and enzyme-linked immunosorbent assay (ELISA).
Results
Normal histology (Table I) Of the 83 patients, 26 (31%) were histologically normal, 9 (20.5%) in the elderly group, 17 (43.6%) in young group). GCLO was grown on culture in only one ofthese and all cases were negative for antibody to the organism.
Chronic superficial gastritis (Table I) Of the 34 patients in this group, the organism was identified histologically in 31 (91%). Twenty-six of the 34 had culture and serology performed -88% were culture positive and antibody was detected in 80%. There was no significant difference between culture and antibody positivity in the two age groups studied.
Atrophic gastritis (Table I) All patients with atrophic gastritis were from the elderly group and were negative for gastric parietal cell and intrinsic factor antibody. Derangement of glandular architecture, thinning of the mucosa with metaplasia, was noted in the antral biopsies in some cases only, and both the antrum and body in others. A variable degree of chronic inflammatory cell exudate into the lamina propria and epithelium was also seen. In 4 cases, no inflammatory cell infiltrate was found (Table II) and these 4 were negative on culture and antibody was not detected. Of the 13 cases with an 
Discussion
This study shows that in patients without peptic ulcer, GCLO was identified histologically in 41%, grown on culture from gastric biopsies in 51.5% and an antibody response detected in 40%. The organism was grown on culture in 88% of the patients with chronic superficial gastritis and an antibody response seen in 81 %. These figures are similar to those reported previously and support the association of the organism with histological gastritis. None of the patients studied had peptic ulcer disease; therefore, if the organism does have an aetiological role, it is with gastritis rather than peptic ulcer in these cases. Of the 33 patients who had antibody, 88% had the organism grown from gastric biopsies and all 33 had histological gastritis. It therefore appears that the presence of antibody to GCLO has predictive value both for the presence of the organism in the stomach and histological gastritis.
The number of elderly patients in the atrophic gastritis group is small and therefore precludes any conclusions being drawn. However, the lack of antibody and the absence of the organism in the stomachs of the patients in this group who did not have an inflammatory exudate into the gastric mucosa, may imply an association between the organism and the local inflammatory response, If so, is the inflammatory response secondary to the organism, or do the inflammatory cells produce changes in the gastric 'internal milieu' allowing the organism to colonize the stomach? This basic question is as yet unanswered. 
